Christopher Labos1, Sara C Martinez2, Rui Hao Leo Wang3, Petra A Lenzini4, Louise Pilote5, Peter Bogaty6, James M Brophy7, James C Engert8, Sharon Cresci9, George Thanassoulis10. 1. Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada. 2. Department of Medicine, Washington University, St. Louis, MO, USA. 3. Department of Biochemistry, McGill University, Montreal, QC, Canada. 4. Department of Genetics, Washington University, St. Louis, MO, USA. 5. Department of Medicine, McGill University, Montreal, QC, Canada. 6. Institut Universitaire de Cardiologie et de Pneumologie, Laval University, Quebec City, QC, Canada. 7. Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada; Department of Medicine, McGill University, Montreal, QC, Canada. 8. Department of Medicine, McGill University, Montreal, QC, Canada; Department of Human Genetics, McGill University, Montreal, QC, Canada. 9. Department of Medicine, Washington University, St. Louis, MO, USA; Department of Genetics, Washington University, St. Louis, MO, USA. 10. Department of Medicine, McGill University, Montreal, QC, Canada. Electronic address: george.thanassoulis@mcgill.ca.
Abstract
BACKGROUND: Limited evidence exists regarding the utility of genetic risk scores (GRS) in predicting recurrent cardiovascular events after acute coronary syndrome (ACS). We sought to determine whether a GRS would predict early recurrent cardiovascular events within 1 year of ACS. METHODS & RESULTS: Participants admitted with acute coronary syndromes from the RISCA, PRAXY, and TRIUMPH cohorts, were genotyped for 30 single nucleotide polymorphisms (SNPs) associated with coronary artery disease (CAD) or myocardial infarction (MI) in prior genome wide association studies. A 30 SNP CAD/MI GRS was constructed. The primary endpoint was defined as all-cause mortality, recurrent ACS or cardiac re-hospitalization within 1 year of ACS admission. Results across all cohorts for the 30 SNP CAD/MI GRS were pooled using a random-effects model. There were 1040 patients from the RISCA cohort, 691 patients from the PRAXY cohort, and 1772 patients from the TRIUMPH cohort included in the analysis and 389 occurrences of the primary endpoint of recurrent events at 1-year post-ACS. In unadjusted and fully adjusted analyses, a 30 SNP GRS was not significantly associated with recurrent events (HR per allele 0.97 (95%CI 0.91-1.03) for RISCA, HR 0.99 (95%CI 0.93-1.05) for PRAXY, 0.98 (95%CI 0.94-1.02) for TRIUMPH, and 0.98 (95%CI 0.95-1.01) for the pooled analysis). Addition of this GRS to the GRACE risk model did not significantly improve risk prediction. CONCLUSION: The 30 MI SNP GRS was not associated with recurrent events 1-year post ACS in pooled analyses across cohorts and did not improve risk discrimination or reclassification indices. Our results suggest that the genetic etiology of early events post-ACS may differ from later events.
BACKGROUND: Limited evidence exists regarding the utility of genetic risk scores (GRS) in predicting recurrent cardiovascular events after acute coronary syndrome (ACS). We sought to determine whether a GRS would predict early recurrent cardiovascular events within 1 year of ACS. METHODS & RESULTS:Participants admitted with acute coronary syndromes from the RISCA, PRAXY, and TRIUMPH cohorts, were genotyped for 30 single nucleotide polymorphisms (SNPs) associated with coronary artery disease (CAD) or myocardial infarction (MI) in prior genome wide association studies. A 30 SNP CAD/MI GRS was constructed. The primary endpoint was defined as all-cause mortality, recurrent ACS or cardiac re-hospitalization within 1 year of ACS admission. Results across all cohorts for the 30 SNP CAD/MI GRS were pooled using a random-effects model. There were 1040 patients from the RISCA cohort, 691 patients from the PRAXY cohort, and 1772 patients from the TRIUMPH cohort included in the analysis and 389 occurrences of the primary endpoint of recurrent events at 1-year post-ACS. In unadjusted and fully adjusted analyses, a 30 SNP GRS was not significantly associated with recurrent events (HR per allele 0.97 (95%CI 0.91-1.03) for RISCA, HR 0.99 (95%CI 0.93-1.05) for PRAXY, 0.98 (95%CI 0.94-1.02) for TRIUMPH, and 0.98 (95%CI 0.95-1.01) for the pooled analysis). Addition of this GRS to the GRACE risk model did not significantly improve risk prediction. CONCLUSION: The 30 MI SNP GRS was not associated with recurrent events 1-year post ACS in pooled analyses across cohorts and did not improve risk discrimination or reclassification indices. Our results suggest that the genetic etiology of early events post-ACS may differ from later events.
Authors: Johan Sundström; Liisa Byberg; Rolf Gedeborg; Karl Michaëlsson; Lars Berglund Journal: Scand J Public Health Date: 2011-01-26 Impact factor: 3.021
Authors: Els Wauters; Kathryn F Carruthers; Ian Buysschaert; Donald R Dunbar; Gilian Peuteman; Ann Belmans; Andrzej Budaj; Frans Van de Werf; Diether Lambrechts; Keith A A Fox Journal: Eur Heart J Date: 2012-11-15 Impact factor: 29.983
Authors: Suzanne V Arnold; Paul S Chan; Philip G Jones; Carole Decker; Donna M Buchanan; Harlan M Krumholz; P Michael Ho; John A Spertus Journal: Circ Cardiovasc Qual Outcomes Date: 2011-07
Authors: Ties A Mulders; Zainna Meyer; Christel van der Donk; Abraham A Kroon; Isabel Ferreira; Coen D A Stehouwer; Sara-Joan Pinto-Sietsma Journal: Int J Cardiol Date: 2010-09-09 Impact factor: 4.164
Authors: M Junyent; K L Tucker; J Shen; Y-C Lee; C E Smith; J Mattei; C-Q Lai; L D Parnell; J M Ordovas Journal: Nutr Metab Cardiovasc Dis Date: 2009-06-05 Impact factor: 4.222
Authors: Riyaz S Patel; Folkert W Asselbergs; Arshed A Quyyumi; Tom M Palmer; Chris I Finan; Vinicius Tragante; John Deanfield; Harry Hemingway; Aroon D Hingorani; Michael V Holmes Journal: J Am Coll Cardiol Date: 2014-03-07 Impact factor: 24.094
Authors: Miguel Chagnon; Jennifer O'Loughlin; James C Engert; Igor Karp; Marie-Pierre Sylvestre Journal: PLoS One Date: 2018-07-19 Impact factor: 3.240
Authors: P L Thompson; J Hui; J Beilby; L J Palmer; G F Watts; M J West; A Kirby; S Marschner; R J Simes; D R Sullivan; H D White; R Stewart; A M Tonkin Journal: BMC Cardiovasc Disord Date: 2022-03-09 Impact factor: 2.298
Authors: Jae-Seung Yun; Sang-Hyuk Jung; Manu Shivakumar; Brenda Xiao; Amit V Khera; Woong-Yang Park; Hong-Hee Won; Dokyoon Kim Journal: Front Cardiovasc Med Date: 2022-08-17